Social Determinants of Health Linked to Receipt of Treatment for Stroke
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 21, 2024 -- For patients with acute ischemic stroke, social determinants of health (SDOH) are associated with the likelihood of receiving thrombolysis or mechanical thrombectomy, according to a study published online Oct. 16 in Neurology.
Chathurika S. Dhanasekara, M.D., Ph.D., from Texas Tech University Health Sciences Center in Lubbock, and colleagues conducted a retrospective cohort analysis using Texas Emergency Department Public Use Data (2016 to 2019), including adults diagnosed with acute ischemic stroke. The risk ratios (RRs) of administering thrombolysis and thrombectomy based on variables representing SDOH and a collective measure (the Social Vulnerability Index [SVI]) were computed.
Data were included for 139,852 patients with ischemic stroke; 12.3 and 4.3 percent received thrombolytic therapy and mechanical thrombectomy, respectively. The researchers found that the likelihood of thrombolysis was lower for those aged older than 65 versus 18 to 45 years (RR, 0.578); Black versus White individuals (RR, 0.801); Hispanic versus non-Hispanic individuals (RR, 0.936); Medicare/Medicaid/Veterans Affairs or uninsured versus private insurance holders (RR, 0.917 and 0.883, respectively); and those in a rural versus urban dwelling (RR, 0.782). Patients in the highest versus lowest quintile of the SVI were less likely to receive thrombolysis (RR, 0.926). The likelihood of receiving thrombectomy was lower for patients aged 65 years or older (RR, 0.787), Black or Hispanic patients (RRs, 0.745 and 0.919), those with Medicare/Medicaid/Veterans Affairs insurance (RR, 0.909), and those from a rural area (RR, 0.909). The SVI was also associated with a lower likelihood of undergoing mechanical thrombectomy (RR, 0.842).
"Our study provides evidence of socioeconomic disparities in access to thrombolysis or thrombectomy for acute ischemic stroke," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Generative AI Model for Draft Radiological Reporting Improves Documentation Efficiency
THURSDAY, June 12, 2025 -- Clinical use of artificial intelligence (AI)-generated draft radiograph reports is associated with improved radiologist documentation efficiency while...
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
THURSDAY, June 12, 2025 -- For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.